✦ LIBER ✦

Effect of intermittent versus continuous androgen deprivation therapy on neuroendocrine (NE) differentiation in prostate carcinoma

✍ Scribed by Franco Di Silverio; Giuseppe Voria; Antonio Cardi; Rossana Lucera; Gianna Mariotti; Alessandro Sciarra

Book ID: 118643577
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 159 KB
Volume: 1
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(02)80199-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of nonsteroidal antiandrogen mono

Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma

✍ Alessandro Sciarra; Franco Di Silverio 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Effect of non-steroidal antiandrogen mon

Effect of non-steroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma

✍ A. Sciarra; V. Gentile; G. Voria; A. Pastore; G. Mariotti; F. Di Silverio 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Trends in the utilization of androgen-de

Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality

✍ Raymond Y. Demers; Ashutosh Tiwari; John Wei; Linda K. Weiss; Richard K. Severso 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

The authors acknowledge the in-depth support of Tsui-Ying Kau, M.P.H., who provided invaluable biostatistical support for our needed access to Detroit area SEER data. They also acknowledge the SEER data itself (contract N01-CN-65054) and appreciate the SEER Program as a vital resource to investigato

EVALUATION OF QUALITY OF LIFE, SIDE EFFE

EVALUATION OF QUALITY OF LIFE, SIDE EFFECTS AND DURATION OF THERAPY IN A PHASE 3 STUDY OF INTERMITTENT MONOTHERAPY VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

✍ F.E. Calais Da Silva; F. Goncalves; A. Santos; J. Kliment; F.M. Calais Da Silva; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

The effect of combined androgen blockade

The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma : Longitudinal evaluation and response to intermittent cyclic etidronate therapy

✍ Terrence Diamond; Joanne Campbell; Carl Bryant; William Lynch 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## BACKGROUND. Androgen receptor blocking agents have become an established form of therapy for men with disseminated prostate carcinoma. The purpose of this study was to evaluate markers of bone turnover and to measure bone mineral densities (BMD) in men with disseminated prostate carcinoma treat

Commentary on “Intermittent versus conti

Commentary on “Intermittent versus continuous androgen deprivation in prostate cancer.” Hussain M, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM Jr, University of Michigan, Division of Hematology/Oncology, Ann Arbor, MI.

✍ Eggener, Scott 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB